 By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Additional Preclinical Data Presented at AACR 2020 On June 22, 2020, ESSA Pharma Inc. EPIX announced new preclinical data was presented at the 2020 American Association for Cancer Research AACR Virtual Annual Meeting II the poster can be accessed here for its lead clinical development candidate EPI-7386, 